Review of Synthetic Routes and Crystalline Forms of the Oncology Drugs Capmatinib, Selpercatinib, and Pralsetinib
2019 ◽
Vol 23
(11)
◽
pp. 2302-2322
◽
2020 ◽
2020 ◽
2016 ◽
Vol 20
(14)
◽
pp. 1512-1546
◽